Design and evaluation of mRNA encoding recombinant neutralizing antibodies for botulinum neurotoxin type B intoxication prophylaxis
Among all natural and synthetic toxins, botulinum neurotoxins (BoNTs), produced by Clostridium botulinum in an anaerobic environment, are the most toxic polymer proteins. Currently, the most effective modalities for botulism prevention and treatment are vaccination and antitoxin use, respectively. H...
Saved in:
Main Authors: | Gulisaina Qiaerxie (Author), Yujia Jiang (Author), Gege Li (Author), Zhixin Yang (Author), Feng Long (Author), Yunzhou Yu (Author), Jian Sheng Lu (Author), Peng Du (Author), Yong Cui (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant botulinum neurotoxin serotype A1 in vivo characterization
by: Cindy Périer, et al.
Published: (2021) -
Neutralizing antibodies to botulinum neurotoxin type A in aesthetic medicine: five case reports
by: Torres S, et al.
Published: (2013) -
Botulinum neurotoxin formulations: overcoming the confusion
by: Samizadeh S, et al.
Published: (2018) -
Botulinum Neurotoxins and Nervous System Future Challenges for Novel Indications
Published: (2020) -
Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin
by: Kexuan Cheng, et al.
Published: (2024)